Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 674
Aptamer sequence: GGGATCGAAACGTAGCGCCTTCGATCCC
Target unique ID: 6322
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_631 12-28 hairpin Molecule Arginine 2.5 nM 10 mM sodium phosphate buffer (pH 7.5) and 100 mM NaCl 8846773
Structure information of aptamer
Aptamer Sequence: GGGATCGAAACGTAGCGCCTTCGATCCC
The optimal secondary structure in dot-bracket notation: (((((((((..........)))))))))
The centroid secondary structure in dot-bracket notation: (((((((((..........)))))))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_631 Description 12-28 hairpin
Aptamer chemistry DNA Length 28 nt
GC content 60.7% Molecular weight 8,574.53 Da
Molarity of 1 μg/μl solution 116.62 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence GGGATCGAAACGTAGCGCCTTCGATCCC
Applications Binding to arginine
Target information
Type Detail Type Detail
PubChem ID 6322 Molecular name Arginine
Molecular formula C6H14N4O2 Molecular weight 174.2
IUPAC name (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid InChIKey ODKSFYDXXFIFQN-BYPYZUCNSA-N
LogP -1.548 Topological polar surface area 127.72
Hydrogen bond acceptor 3 Hydrogen bond donor 4

Synonym(s):
L-arginine; arginine; 74-79-3; L-(+)-Arginine; L(+)-Arginine; L-Arg; (S)-2-Amino-5-guanidinopentanoic acid; H-Arg-OH; (L)-Arginine; Arginina; ARGININE, L-; Arginine (VAN); L-Arginin; Argininum [INN-Latin]; Arginina [INN-Spanish]; L-Ornithine, N5-(aminoiminomethyl)-; Argamine; Argivene; Detoxargin; Levargin; L-alpha-Amino-delta-guanidinovaleric acid; Minophagen A; 1-Amino-4-guanidovaleric acid; CCRIS 3609; (S)-(+)-arginine; NSC 206269; arg; HSDB 1429; AI3-24165; UNII-94ZLA3W45F; (S)-2-Amino-5-guanidinovaleric acid; BRN 1725413; CHEBI:16467; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; L-Norvaline, 5-((aminoiminomethyl)amino)-; MFCD00002635; 2-amino-5-guanidinovaleric acid; CHEMBL1485; (2S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; 94ZLA3W45F; Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; L-Arginine, monohydrochloride; Arginine (L-Arginine); R-Gene; L-Norvaline, 5-[(aminoiminomethyl)amino]-; (2S)-2-amino-5-carbamimidamidopentanoic acid; DSSTox_CID_21056; DSSTox_RID_79618; DSSTox_GSID_41056; C6H14N4O2; Argininum; Pentanoic acid, 2-amino-5-[(aminoiminomethyl)amino]-, (S)-; Arginine [USAN:INN]; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; CAS-74-79-3; Arginine [USP:INN]; EINECS 200-811-1; 2-AMINO-5-GUANIDINO-PENTANOIC ACID; NSC203450; 3h-l-arginine; L-Arginine, labeled with tritium; 1laf; NSC-206269; L-a-Amino-d-guanidinovaleric acid; NCGC00015064-02; (S)-Arginine; L(+) arginine; L-Aryginine,(S); H-Arg; L-(+) arginine; L(+)-Arginine;; L-Arginine (9CI); Arginine (USP/INN); Tocris-0663; (2S)-2-amino-5-guanidino-pentanoic acid; L-Arginine (JP17); GND; Lopac-A-5006; Arginine, L- (8CI); bmse000029; bmse000899; bmse000919; Epitope ID:140084; L-Arginine (H-Arg-OH); EC 200-811-1; SCHEMBL1791; 2-amino-5-guanidinovalerate; Lopac0_000077; Arginine hydrochloride(USAN); GTPL721; 4-04-00-02648 (Beilstein Handbook Reference); L-a-Amino-d-guanidinovalerate; L-Amino-4-guanidovaleric acid; US9138393, L-Arginine; US9144538, L-Arginine; 1-Amino-4-guanidovalerlic acid; DTXSID6041056; BDBM21959; L-Arginine, 99%, FCC, FG; BDBM181132; HMS3260O15; N5-(aminoiminomethyl)-L-Ornithine; HY-N0455; ZINC1532525; L-Arginine, Vetec(TM), 98.5%; Tox21_113046; Tox21_500077; AC-083; L-2-Amino-5-guanidinopentanoic acid; L-alpha-Amino-delta-guanidinovalerate; L-Arginine, reagent grade, >=98%; s5634; AKOS006239069; AKOS015854096; Tox21_113046_1; AM81500; CCG-204172; DB00125; LP00077; MCULE-5108123240; SDCCGSBI-0050065.P002; L-Arginine, 99%, natural, FCC, FG; (s)-2-amino-5-guanidino-pentanoic acid; 5-[(aminoiminomethyl)amino]-L-Norvaline; NCGC00015064-01; NCGC00024715-01; NCGC00024715-02; NCGC00024715-03; NCGC00024715-04; NCGC00024715-05; NCGC00024715-10; NCGC00260762-01; 4455-52-1; AS-14190; K277; L-Arginine, BioUltra, >=99.5% (NT); SBI-0207062.P001; AB0014136; A0526; A7079; EU-0100077; L-Arginine, SAJ special grade, >=98.0%; A 5006; C00062; D02982; L-Arginine, Vetec(TM) reagent grade, >=98%; M02981; 14932-EP2316830A2; 2-azaniumyl-5-(diaminomethyleneammonio)pentanoate; AB00374192_03; Norvaline, 5-[(aminoiminomethyl)amino]-, (L)-; 002A635; A837397; A929348; Q173670; SR-01000075479; SR-01000597671; (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoate; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoate; SR-01000075479-1; SR-01000597671-1; W-104410; (S)-2-amino-5-[(aminoiminomethyl)amino]-Pentanoic acid; Arginine, European Pharmacopoeia (EP) Reference Standard; (2S)-2-amino-5-[(diaminomethylidene)amino]pentanoic acid; 7F15B0C7-356D-45D7-AC33-03AEE4394A0E; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; UNII-0O72R8RF8A component ODKSFYDXXFIFQN-BYPYZUCNSA-N; UNII-FL26NTK3EP component ODKSFYDXXFIFQN-BYPYZUCNSA-N; (2S)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid; L-Arginine, United States Pharmacopeia (USP) Reference Standard; L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material; L-; L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%; L-Arginine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture

Activity data

No relevant experimental diagram

Interaction ID 674
Target type Molecule
Target unique ID 6322
Activity 2.5 nM
Binding Conditions/Buffer

10 mM sodium phosphate buffer (pH 7.5) and 100 mM NaCl

Assay

N/A

PubMed ID 8846773
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_361 DNA GGGAACGCCCGTATTGCTCGGTTCCC 64.29%
Apta_360 DNA GGGAACGCATACGCCGCAGTATTTCCC 60.71%
Apta_362 DNA GGGAACGCACCGATCGCAGGTTTCCC 60.71%
Apta_1146 DNA GGGACAGGGAGTGCGCTGCTCCCC 60.71%
Apta_672 DNA GGGGTGAAACGGGTCCCG 57.14%
Apta_358 DNA GGGAATCGCCACCCGACGCAGGGTTTCCC 55.17%
Apta_1254 DNA GGCAGTGTGGGCGAATCTATGCGTACCGTTCGATATCGTG 55.00%
Apta_602 DNA GGGCGAGAACAGTGTCCCAGTCGCTAGTTTTCTCTGCCC 53.85%
Apta_1138 DNA GCAGTGTGGGCGAATCTATGCGTACCGTTCGATATCGTG 53.85%
Apta_196 DNA AGGAAGGCTTTAGGTCTGAGATCTC 53.57%
Apta_359 DNA GGGAACGCGTTATTGGGTAACTTCCC 53.57%
Apta_1242 DNA GGAGCGATTAGTAGTGGTCTTGTCTTTTGC 53.33%
Apta_338 DNA GGGCGCGTTCTTCGTGGTTACTTTTAGTCCCG 53.12%
Apta_876 DNA GTTGCGAAAGACAACGAATGCTTTGCCTGCCATAATTTGC 52.50%
Apta_423 DNA TGGGAGCTGATGTCGCATGGGTTTTGATCACATGA 51.43%
Apta_462 DNA GGTATAGACCCCTGAGTCCTACCGAGGGCACGGCA 51.43%
Apta_229 DNA GGGGCACGTTTATCCGTCCCTCCTAGTGGCGTGCCCC 51.35%
Apta_158 DNA CACAGGCTACGGCACGTAGAGCATCACCATGATCCTGTG 51.28%
Apta_1026 DNA GGGGGGTGTATCGTTGACGAGTTGCGCGTGCGTCTCGTG 51.28%
Apta_1027 DNA GGAGCTACGTTTAGCGAGTCCGACGCTCGGTGCCTCTTC 51.28%